AT1 FY21 - General Discussion + FA, page-24

AT1's quarterly is due in about 3 weeks, what do you guys expect from the quarterly

We got TGA approval, but we don't know if there are any sales(do they have to announce if the sales are not significant?)

We got access bio and divoc lab deal, but except for the 77,000 devices to divoc, we are still waiting for approval.

We got the non-exclusive right to sell access bio antigen test in a few countries, but I guess we wouldn't see any sales this quarter

We got the deal from NG-biotech, but we don't know if they ordered, and how much they ordered.

So when I was thinking about it last night, I don't know if we could expect much from the COVID side of the business

The only thing I think we are sure of is that we are still selling HIV tests and other OEM products to all the existing partners. But the question is how much did we sell?

To sum up, I'm trying to have a low expectation of the revenue figure for the upcoming quarterly. Even though we have many deals coming in but they are not materialized yet.

Correct me if anything is wrong, and I would like to hear other opinions as I'm not very optimistic about the upcoming quarterly.